Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001453072-18-000063
Filing Date
2018-02-14
Accepted
2018-02-14 15:11:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 alsk12311713g-a2WINT.txt SC 13G/A 17237
  Complete submission text file 0001453072-18-000063.txt   19078
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52027 | Film No.: 18611508
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

IRS No.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A